In a quality review of glucose monitors, we measured the inaccuracy and imp
recision of 26 systems. In each case, measurements on at least 50 capillary
specimens from diabetic patients were compared with results from capillary
blood that had been deproteinized and assayed with hexokinase. We also tes
ted the monitors with commercial control solutions. In patients' specimens
having a mean blood glucose concentration of about 9 mmol/l, the bias of th
e 26 monitors ranged from -5.1 to +20.1% (median = +7.5%). Imprecision of t
he monitors with blood specimens gave coefficients of variation (CV) rangin
g from 4.5% to 22.8% (median = 8.7%) at the mean glucose concentration. A c
ontrol solution for the monitors gave a glucose concentration of 7.6-13.6 m
mol /1 (median = 9.2 mmol/l) with CV that varied from 1.7 to 19.8% (median
= 4.7%). While the means and CV's of the control were significantly correla
ted with bias and imprecision of the blood specimens, much of the variance
remained unexplained (for bias, r(2) = 0.17; for imprecision, r(2) = 0.43).
We conclude that a common basis for calibration could remove a significant
component of variation and that control solutions may give a false impress
ion of analytical performance. (C) 2001 Elsevier Science B.V. All rights re
served.